Radiofrequency ablation versus antiarrhythmic drugs in first-line treatment of atrial fibrillation

被引：0
|
作者：
不详
机构：
来源：
SAMJ SOUTH AFRICAN MEDICAL JOURNAL | 2005年 / 95卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：486 / +
页数：2
相关论文
共 50 条
  • [1] Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation - A randomized trial
    Wazni, OM
    Marrouche, NF
    Martin, DO
    Verma, A
    Bhargava, M
    Saliba, W
    Bash, D
    Schweikert, R
    Brachmann, J
    Gunther, J
    Gutleben, K
    Pisano, E
    Potenza, D
    Fanelli, R
    Raviele, A
    Themistoclakis, S
    Rossillo, A
    Bonso, A
    Natale, A
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (21): : 2634 - 2640
  • [2] Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation (RAAFT-2) A Randomized Trial
    Morillo, Carlos A.
    Verma, Atul
    Connolly, Stuart J.
    Kuck, Karl H.
    Nair, Girish M.
    Champagne, Jean
    Sterns, Laurence D.
    Beresh, Heather
    Healey, Jeffrey S.
    Natale, Andrea
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (07): : 692 - 699
  • [3] Ablation Versus Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation A Meta-Analysis of Randomized Trials
    Kheiri, Babikir
    Simpson, Timothy F.
    Przybylowicz, Ryle
    Merrill, Miranda
    Alhamoud, Hani
    Osman, Mohammed
    Dalouk, Khidir
    Stecker, Eric
    Henrikson, Charles A.
    Nazer, Babak
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2021, 14 (08):
  • [4] Ablation Versus Drugs: What Is the Best First-Line Therapy for Paroxysmal Atrial Fibrillation? Antiarrhythmic Drugs Are Outmoded and Catheter Ablation Should Be the First-Line Option for All Patients With Paroxysmal Atrial Fibrillation: Con
    Hanley, Colleen M.
    Esberg, Douglas
    Kowey, Peter R.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2014, 7 (04): : 747 - +
  • [5] Ablation Versus Drugs: What Is the Best First-Line Therapy for Paroxysmal Atrial Fibrillation? Antiarrhythmic Drugs Are Outmoded and Catheter Ablation Should Be the First-Line Option for All Patients With Paroxysmal Atrial Fibrillation: Con Response
    Santangeli, Pasquale
    Di Biase, Luigi
    Natale, Andrea
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2014, 7 (04): : 754 - 754
  • [6] Ablation Versus Antiarrhythmic Drugs as First-Line Therapy for Treatment-Naive Atrial Fibrillation: A Systematic Review and Meta-Analysis
    Ullah, Waqas
    Johnson, Drew
    Nair, Abhinav S.
    Dikdan, Sean J.
    Frankel, Eitan
    Humayun, Wajahat
    Pavri, Behzad B.
    Frisch, Daniel
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 213 : 63 - 68
  • [7] Typical atrial flutter: Antiarrhythmic drugs or ablation as first-line therapy?
    Marrouche, NF
    Natale, A
    CARDIAC ARRHYTHMIAS 2001, 2002, : 291 - 300
  • [8] ABLATION VS ANTIARRHYTHMIC DRUGS AS FIRST-LINE TREATMENT OF PAROXYSMAL ATRIAL FIBRILLATION: A META-ANALYSIS OF RANDOMIZED TRIALS
    Kheiri, Babikir
    Simpson, Timothy
    Przybylowicz, Ryle
    Merrill, Miranda
    Alhamoud, Hani
    Osman, Mohammed
    Dalouk, Khidir
    Stecker, Eric
    Henrikson, Charles
    Nazer, Babak
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 355 - 355
  • [9] Catheter Ablation is Superior to Antiarrhythmic Drugs as First-Line Treatment for Atrial Fibrillation: a Systematic Review and Meta-Analysis
    Cardoso, Rhanderson
    Justino, Gustavo B.
    Graffunder, Fabrissio P.
    Benevides, Leticia
    Knijnik, Leonardo
    Sanchez, Luana M. F.
    D'Avila, Andre
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2022, 119 (01) : 87 - 93
  • [10] CATHETER ABLATION IS SUPERIOR TO ANTIARRHYTHMIC DRUGS AS FIRST-LINE TREATMENT FOR ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Cardoso, Rhanderson
    Justino, Gustavo B.
    Knijnik, Leonardo
    Soares, Leticia B. C.
    Sanchez, Luana M. F.
    Graffunder, Fabrissio P.
    d'Avila, Andre
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 384 - 384
12345